RedHill Biopharma Ltd. received approval from Brazil’s health regulator for its global Phase 2/3 study, which evaluates its proprietary inhibitor called opaganib in …
RedHill Biopharma Ltd. (RDHL) said on Monday that its first coronavirus patient has been treated with with the company’s new proprietary drug called …
The objective of any investor is a simple one: to make money. While this objective couldn’t be clearer, it is much harder putting …
RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) released positive top-line results from the Phase III GUARD study with BEKINDA® (RHB-102) 24 mg for acute …
In a research report released today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) with a $27.50 price …
In a research report issued today, Roth Capital analyst Scott Henry reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) and raised his price …
MLV analyst Vernon Bernardino is out with a research report on RedHill Biopharma (NASDAQ:RDHL), reiterating a Buy rating and a $25 price target, which represents a potential …
In a research report issued today, MLV analyst Vernon Bernardino reiterated a Buy rating on RedHill Biopharma (NASDAQ:RDHL) but slightly reduced his price target …
In a research report issued today, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (NASDAQ:RDHL), with a price target of …
In a research note issued this morning, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (RDHL) and raised his price target …
